INTERESTING EYE NEWS & CLINICAL PEARLS

Dietary Omega-3 Fatty Acids and Ganglion Cell Function -- Nguyen et al. 49 (8): 3586 -- Investigative Ophthalmology & Visual Science : "Increasing dietary -3 has beneficial effects across the retina, with the greatest improvement occurring in ganglion cell function."

Dietary Omega-3 Fatty Acids and Ganglion Cell Function -- Nguyen et al. 49 (8): 3586 -- Investigative Ophthalmology & Visual Science : "Increasing dietary -3 has beneficial effects across the retina, with the greatest improvement occurring in ganglion cell function."

Oral Niacin Can Increase Intraocular Pressure The intraocular pressure of a 73-year-old man with a history of primary open-angle glaucoma had been approximately 21 and 17 mm Hg in the right and left eyes, respectively, while taking latanoprost 0.005% and dorzolamide hydrochloride 2%. When taking 500 mg of oral niacin (also known as vitamin B3 or nicotinic acid), his intraocular pressure increased to 28 and 23 mm Hg in the right and left eyes, respectively. Each time the niacin was stopped, the intraocular pressure decreased to the original levels. [Ophthalmic Surg Lasers Imaging 2008;39:341-342.]

These data suggest that the time to control of ocular inflammation is faster with mycophenolate than with methotrexate. Azathioprine therapy has a higher rate of treatment-related side effects compared with the other 2 agents.

Vision-related quality of life, cognitive impairment, and depressive mental status are all strongly related with each other. Cataract surgery significantly improved vision-related quality of life in elderly patients, and cognitive impairment and depressive mental status also improved in parallel with improvement in vision-related quality of life.

Visual prognosis after BRAO seems to be correlated to presenting VA. Eyes with initial VA of 20/40 or better usually remained at 20/40 or better. Individuals with poor VA of 20/100 or worse generally did not show the significant improvement reported in previous studies.

conclusion: Bimatoprost-treated eyes demonstrated less long-term fluctuation in IOP compared with latanoprost-treated eyes in this six-month study.